CareRx Announces Q3 2026 Dividend

Q: What dividend did CareRx (CHHHF) declare for Q3 2026?

CareRx declared a Q3 2026 dividend of CAD$0.022 per common share . According to CareRx, it will be paid on October 8, 2026, to shareholders of record at the close of business on September 15, 2026.

Q: When is the record date and payment date for the CareRx (CHHHF) Q3 2026 dividend?

The record date is September 15, 2026 , and the payment date is October 8, 2026 . According to CareRx, shareholders of record on the record date will receive CAD$0.022 per outstanding common share.

Q: Is the CareRx (CHHHF) Q3 2026 dividend an eligible dividend for Canadian tax purposes?

Yes, the Q3 2026 CareRx dividend is designated as an eligible dividend for Canadian income tax purposes. According to CareRx, this designation may impact how the dividend is taxed for Canadian resident shareholders.

Q: How are CareRx (CHHHF) Q3 2026 dividends taxed for non-residents of Canada?

Non-resident shareholders are subject to Canadian withholding tax on the Q3 2026 dividend. According to CareRx, applicable tax treaty provisions may reduce the withholding rate, and investors should consult a tax advisor about their specific situation.

Q: How are CareRx (CHHHF) dividends to U.S. residents taxed for Q3 2026?

Dividends paid to U.S. residents are taxed under the U.S. Internal Revenue Code . According to CareRx, U.S. shareholders should consult a tax advisor to understand how the Q3 2026 CAD$0.022 dividend applies to their individual tax circumstances.

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

CareRx (OTC: CHHHF, TSX: CRRX) announced that its Board has declared a quarterly dividend of CAD$0.022 per common share, payable on October 8, 2026 to shareholders of record as of the close of business on September 15, 2026. The dividend is designated as an eligible dividend for Canadian tax purposes, and non-resident holders may be subject to withholding tax, potentially reduced by treaty.

Positive

Q3 2026 dividend declared CAD$0.022 per common share
Clear payment timeline record date September 15, 2026; payable October 8, 2026
Eligible dividend status may offer tax advantages for Canadian shareholders

Negative

None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

07/29/2026 - 06:20 PM

Toronto, Ontario--(Newsfile Corp. - July 29, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today announced that the Company's Board of Directors has declared a dividend of CAD$0.022 per outstanding common share of the Company ("Common Shares"), payable on October 8, 2026, to holders of record of Common Shares as of the close of business on September 15, 2026. This dividend is designated as an "eligible dividend" for Canadian income tax purposes. Dividends paid or credited to non-residents of Canada are subject to withholding tax, which may be reduced by treaty. Taxation of dividends paid to U.S. residents is governed by the Internal Revenue Code. The Company advises shareholders to consult a tax advisor to determine any tax consequences of receiving dividends from CareRx.

About CareRx Corporation

CareRx is Canada's leading provider of pharmacy services to seniors living and other congregate care communities (long-term care homes, retirement homes, assisted living facilities and group homes). We are a national organization with a large network of pharmacy fulfillment centers strategically located across the country. This allows us to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. We use best-in-class technology that automates the preparation and verification of multi-dose compliance packaging of medication, providing the highest levels of safety and adherence for individuals with complex medication regimens. We take an active role in working with our home operator partners to promote resident health, staff education and medication system quality and efficiency.

For additional information, visit www.carerx.ca or contact:

Neil Weber
Investor Relations
LodeRock Advisors
(647) 222-0574
neil.weber@loderockadvisors.com

Corporate Logo

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/307219

FAQ

What dividend did CareRx (CHHHF) declare for Q3 2026?

CareRx declared a Q3 2026 dividend of CAD$0.022 per common share. According to CareRx, it will be paid on October 8, 2026, to shareholders of record at the close of business on September 15, 2026.

When is the record date and payment date for the CareRx (CHHHF) Q3 2026 dividend?

The record date is September 15, 2026, and the payment date is October 8, 2026. According to CareRx, shareholders of record on the record date will receive CAD$0.022 per outstanding common share.

Is the CareRx (CHHHF) Q3 2026 dividend an eligible dividend for Canadian tax purposes?

Yes, the Q3 2026 CareRx dividend is designated as an eligible dividend for Canadian income tax purposes. According to CareRx, this designation may impact how the dividend is taxed for Canadian resident shareholders.

How are CareRx (CHHHF) Q3 2026 dividends taxed for non-residents of Canada?

Non-resident shareholders are subject to Canadian withholding tax on the Q3 2026 dividend. According to CareRx, applicable tax treaty provisions may reduce the withholding rate, and investors should consult a tax advisor about their specific situation.

How are CareRx (CHHHF) dividends to U.S. residents taxed for Q3 2026?

Dividends paid to U.S. residents are taxed under the U.S. Internal Revenue Code. According to CareRx, U.S. shareholders should consult a tax advisor to understand how the Q3 2026 CAD$0.022 dividend applies to their individual tax circumstances.